About us
SPGL is a professional services group, servicing a range of market sectors including Pharmaceuticals & Biotechnology, Regulated Consumer Products, Healthcare, Chemicals, Buildings and Mission Critical facilities such as Data Centres.
The group is headquartered in London with an office in Brussels, Belgium with multiple projects world-wide including UK, Belgium, Holland, Germany, Poland and the USA among others.
SPGL was formed as a result of a successful Management Buyout of the assets of Skanska Pharmaceutical Group Limited. The group was a wholly owned subsidiary of Skanska USA Building Incorporated which has been set up to support and serve the Science and Technology Market sector. The group was originally formed in 2003 and SPGL started business after the acquisition was successfully completed on 1st August 2008.
“Managing Quality, Improving Performance”
The core competency of the group is Managing Quality for all our customers across all market sectors.
Our Vision is to Improve Performance resulting in increased productivity for our customers.
The mission of SPGL is to work/partner with its customers to improve productivity through the effective implementation of:
Quality
Meeting our Customers requirements.
Risk Management
Helping clients achieve the most cost-effective solutions by combining our knowledge of regulations, good practice and risk management experience.
Reduced Time to Market
Our ability to integrate engineering, construction and commissioning reduces our clients' time to market.
“Project Management – Purity in delivery”. Wael Allan, Author (co-authored with Bill Flemming and Philip Southerland, Skanska).
Read this article >
Project Delivery and Consulting Services
Commissioning Services
